No photo of Flemming Steen Jørgensen

Flemming Steen Jørgensen

1979 …2019

Research activity per year

Network

J Edgar Anderson

  • University College London

External person

Lars Carlsen

  • Danmarks Tekniske Universitet
  • University of Copenhagen
  • Rise Laboratory
  • Roskilde University

External person

James P. Snyder

  • Emory University, Atlanta
  • University of Copenhagen

External person

Gunnar Houen

  • Statens Serum Institut

External person

Olivier Taboureau

  • Danmarks Tekniske Universitet

External person

Leif Nørskov-Lauritsen

  • University of Copenhagen

External person

Nico P E Vermeulen

  • Vrije Universiteit Brussel

External person

Chris Oostenbrink

  • Vrije Universiteit Brussel

External person

Michael N. Paddon-Row

  • The University of New South Wales

External person

Jan N M Commandeur

  • Vrije Universiteit Brussel

External person

B Bjørnholm

  • Royal Danish School of Pharmacy

External person

R.S.,Jr. Brown

  • University of Alberta

External person

Chris Oostenbrink

  • University of Natural Resources and Life Sciences

External person

Fritz Duus

  • Roskilde University
  • University of Copenhagen
  • Rise Laboratory

External person

Harish K. Patney

  • The University of New South Wales

External person

Inge Thøger Christensen

  • Novo Nordisk A/S (Biz)

External person

Andrew J Benie

  • Novo Nordisk A/S (Biz)
  • Novo Nordisk A/S

External person

Peter Gerd Bross

  • Institut for Klinisk Medicin - Molekylær Medicinsk Forsk.enhed

External person

J. M. Buschek

  • University of Alberta

External person

Tove Thomsen

  • University of Copenhagen

External person

Nanna Larsen

  • Statens Serum Institut

External person

Jaakko Aaltonen

  • University of Helsinki

External person

Niclas Tue Hansen

  • Department of Systems Biology

External person

Nico P E Vermeulen

  • Vrije Universiteit Amsterdam

External person

Chris Oostenbrink

  • University of Natural Resources and Life Sciences, Vienna

External person

Anders L Nielsen

  • Novo Nordisk A/S (Biz)

External person

Michael Gaihede

  • Øre-næse-halssygdomme
  • University of Copenhagen

External person

Hans G. Guttenberger

  • Friedrich-Alexander University Erlangen-Nürnberg

External person

Phaedria M St. Hilaire

  • Novo Nordisk A/S (Biz)

External person

S Hansen

  • Institut for Cellulær og Molekylær Medicin, Københavns Universitet

External person

Ram P. Kashyap

  • Texas Christian University

External person

Karl R. Kopecky

  • University of Alberta

External person

Anders N. Hansen

  • Department of Medicinal Chemistry, The Danish University of Pharmaceutical Sciences, Copenhagen

External person

Nico P E Vermeulen

  • Vrije Universiteit Brussel

External person

Jozef Hritz

  • Vrije Universiteit Brussel

External person

Peter Højrup

  • University of Southern Denmark

External person

J. R. Byberg Buur

  • University of Copenhagen

External person

Kjeld Schaumburg

  • Institut for Natur, Systemer og Modeller

External person

Tina Friis

  • Statens Serum Institut

External person

Jeroen Lastdrager

  • Vrije Universiteit Brussel

External person

Peter Højrup

  • University of Southern Denmark

External person

Hans J. Bestmann

  • Friedrich-Alexander University Erlangen-Nürnberg

External person

Ming Chen

  • Copenhagen University Hospital

External person

E. Falch

  • University of Copenhagen

External person

Casper Lyngholm-Kjærby

  • University of Copenhagen

External person

Laurent David

  • H. Lundbeck A/S

External person

Khanhvi Phuc Tran

  • University of Copenhagen

External person

Bogac Ercig

  • University of Copenhagen

External person

Roald Boe Jensen

  • University of Copenhagen

External person

Olivier Taboureau

  • Technical University of Denmark

External person

Morten Larsen

  • Department of Drug Design and Pharmacology, KU

External person

Irene Kouskoumvekaki

  • Center for Biological Sequence Analysis, Technical University of Denmark

External person

Ingrid Petersson

  • Department of Medicinal Chemistry, The Danish University of Pharmaceutical Sciences, Copenhagen

External person

Gustav Sshroll

  • University of Copenhagen

External person

Grethe Rindorf

  • Danmarks Tekniske Universitet

External person

Bruno Frei

  • Eidgenossische Technische Hochschule Zurich

External person

Helge Egsgaard

  • CHEC Research Centre
  • Danmarks Tekniske Universitet

External person

Bjarke Ebert

  • H. Lundbeck A/S

External person

Søren F Christensen

  • Novo Nordisk A/S (Biz)

External person

Qiyuan Li

  • Department of Systems Biology

External person

Dietmar Geiger

  • University of Würzburg

External person

Ismael Zamora

  • IMIM Universitat Pompeu Fabra

External person

Kristina Luthman

  • Göteborg University

External person

Tudor Oprea

  • Center for Biological Sequence Analysis, Technical University of Denmark

External person

Jan Høst

  • Ferrosan A/S

External person

Morten Pilgaard

  • Department of Medicinal Chemistry, The Danish University of Pharmaceutical Sciences, Copenhagen

External person

Christine D. Bendiksen

  • Statens Serum Institut

External person

Lene Sylvest

  • Statens Serum Institut

External person

H. Hjeds

  • University of Copenhagen

External person

Gabriele Cruciani

  • University of Perugia

External person

Henning Thøgersen

  • Novo Nordisk A/S

External person

Hanne B. Rasmussen

  • Department of Medicinal Chemistry, The Danish University of Pharmaceutical Sciences, Copenhagen

External person

Benny Bang-Andersen

  • H. Lundbeck A/S

External person

Franz L. Dickert

  • University of Copenhagen

External person

T W Schwartz

  • Bioscience Novo Nordisk A/S

External person

Uli Hacksell

  • Uppsala University

External person

James M. Flink

  • Novo Nordisk A/S (Biz)

External person

William H. Watson

  • Texas Christian University

External person

Jan Egebjerg

  • H. Lundbeck A/S

External person

Tobias B. Rasmussen

  • Analytical Biosciences, Department of Pharmacy, University of Copenhagen

External person

A. Lagersted

  • University of Copenhagen

External person

Julie Islin

  • Section for Pharmaceutical Design and Drug Delivery, Department of Pharmacy, University of Copenhagen

External person

Morten Thaysen-Andersen

  • University of Southern Denmark

External person

L. Brehm

  • Dept. Med. Chem., Roy. Danish S.

External person

Lars Olsen

  • Danish University of Pharmaceutical Sciences

External person

Anthony Long

  • Lhasa Limited

External person

Tina Nielsen

  • University of Southern Denmark

External person

Jan M N Commandeur

  • Vrije Universiteit Amsterdam

External person